Rates of severe nausea or vomiting were reported in 3 to 8 percent of GLP-1 users, but confirmed gastroparesis diagnoses requiring gastric emptying studies were extremely rare
Therefore, this resource aims to provide a wide range of treatment ideas that can be customized to meet patients' specific needs
Doctors should understand these to help patients deal with insurance issues
Before starting or switching between semaglutide alternatives, discuss your genetic predisposition data and clinical presentation with a qualified healthcare provider
Even in states that theoretically cover these medications, approval processes can be lengthy and denials common
Research has explored its potential in dermatology, hair restoration, and tissue regeneration, although many applications remain investigational and are not FDA-approved for therapeutic claims